Torisel News
Most Popular Torisel Story
Novartis ends cancer trial early after hitting endpoint
Novartis has brought a late-stage study of its kidney cancer drug everolimus to a premature close after an independent review committee determined the therapy had extended patients' lives without... Read more...
Latest Headlines
- February 28, 2008
- January 9, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
